Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma

Background: Syndecan-1 (CD138) is expressed by the Hodgkin-Reed-Sternberg (HRS) cells of classic Hodgkin's lymphoma (cHL), but not in nodular lymphocyte-predominant HL. Syndecan-1 may be involved in the interaction between HRS cells and the cellular and stromal microenvironment typical of nodul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2005-11, Vol.25 (6C), p.4743-4746
Hauptverfasser: VASSILAKOPOULOS, Theodoros P, KYRTSONIS, Marie-Christine, KOKORIS, Styliani I, DIMITRIADOU, Evangelia M, TSAFTARIDIS, Panayiotis, PIZZOLO, Giovanni, PANGALIS, Gerassimos A, PAPADOGIANNIS, Argiroula, NADALI, Gianpaolo, ANGELOPOULOU, Maria K, TZENOU, Tatiana, DIMOPOULOU, Maria N, SIAKANTARIS, Marina P, KONTOPIDOU, Flora N, KALPADAKIS, Christina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Syndecan-1 (CD138) is expressed by the Hodgkin-Reed-Sternberg (HRS) cells of classic Hodgkin's lymphoma (cHL), but not in nodular lymphocyte-predominant HL. Syndecan-1 may be involved in the interaction between HRS cells and the cellular and stromal microenvironment typical of nodular sclerosing HL. Patients and Methods: Serum levels of soluble syndecan-1 were determined by ELISA in 66 patients with HL and 14 age- and sex-matched healthy individuals. Results: The levels of syndecan-1 were higher in HL patients than controls (100.2±35.9 ng/ml vs. 67.9±24.5 ng/ml, p
ISSN:0250-7005
1791-7530